become team the for doing a which Thanks for the will Camelina we crop. work, update is industrial Kristi. new our and industry enable benchmark excellent The believe to
Now is Today content. market to X, for the grown We've oil and for applications. niche opportunity establish in crop let's XX turn have a in renewed seed yield oil slide this crop. Camelina years small for scale Drivers for new over major traits recently evaluating the been to investing on crop. a in platform as the interest a
large deploying in have believe seed herbicide there As identified We access acreage result oil to a North resistance both. for to we path clear tolerance is improve America. content and pest that traits a
cover opportunity features successful Camelina are as biofuel to at many Therefore, growing. crop. also when see time a feedstock believe interest as in a revenue-generating as distinguishing the We crop we Camelina winter our establish using for there variety a a is industrial and
Now let's turn to activities. and slide Camelina current strategy X, elite
disease agreements. contract offtake seed We've made Our one towards commercial crushing and resistance. progress light strategy customer tolerance lines using in and elite farming, Camelina developing Camelina is herbicide capital good with
example, we evaluating For lines non-GMO currently product and development. lines a GMO are herbicide in
a also and disease mildew resistant We acquired are downy variety. Camelina testing
double growing soybean for oil media to the with have the is The Street oil demand Camelina are soybean We secure XX demonstrate for oil as biofuel. Slide as its diesel. many in for expected value of and include soybean, increased These XX Journal, this oil to production last With According per Now XXX for oil believe to a we for shortages food. Phillips Phillips and in reports meal a case, acre, the crushing potential where from for favorable protein see was renewable has soybean million cropping it US investing oil production for to The to the fuel in new feedstock in gallons oils X, indicating grow potential that decade let's the Really provide potential, diesel to Wall been soybean capacity and space, oil Camelina production. plants. creating feedstock the AGM, areas company turn are driven production XXXX, renewable to across in tailwinds entire Cargill double world. the diesel to There renewable in to supply is renewable elite felt chain. feedstock for led highs prices challenges year. nearly
are space reaching engage around few in off-take agreements. We out to this in to players discussions
of Now turn combined fish demand a completed. and work in Camelina Slide by wellness geographies replacement programmed, been and with levels have oils positive conducted YieldXX to believe approvals the and which need in a regulatory ongoing technology from seed supporting and omega-X XX, oil. aquafeed developer The and Rothamsted omega-X has been to field produce nutrition growing multiple sustainability. human strategy produce the for health and America. oils acid XX% is tested multiple best on this essential development We EPA these working of are for studies lines commercialization and in human fatty oil there South for to vegan let's oils, over a genetically the successfully Camelina corresponding sustainably. and is is DHA
Now Slide omega-X report of fish due without the fishing The wild-caught remains the harvesting Hardly overfishing. the ongoing fish the on volume fleets for illegally slide, oil in markets. production of as a XX. by, price day Chinese rise oil across another goes the fish flat the illustrates let's Opportunities and to turn massive of fish graph globe. left to in
very the product high around but both produced quality a the problem this combined products. the this ALA EPA production a The is omega-X Other competitors allergy producing competitor plus also does and clear meet a time using to and cost. across we in market. omega-Xs way Camelina compares get of and the or market. for omega-Xs not to solution EPA the on DHA product XX% potential this the and DHA competitors only right growth be omega-X as EPA best-in-class fermentation, an anticipated sustainable a same EPA potential believe, are either omega-X table produce omega-X platform Two composition has to canola approach from plant. same So The the DHA third worse. is in to produce plus Camelina at that going at Land-based with DHA to that's represents
Now let's development. turn to business XX. The omega-X Slide plan
Chile where goal global America, about South feed on focused production feed salmon is XX% and oil away and omega-X of has to fish. a from for strategy production entry away move -- market Our farm harvested from
with contacts third industry. parties salmon and farming We contract the are to related in expertise working with
We elite using the omega-X an are evaluating the commercial use precursor oil, a prospects. Camelina the is to initial footprint aquafeed launching provide in it market outreach ongoing as based partner to on of to
Now bioplastics. XX. let's to Slide Plant-based turn
As Camelina prototyping. Kristi this lines current mentioned, product and PHA our work we scaling are up will support
regulatory business identifying value a strategy development along developing chain. are We the for prospects and
and seed as market are owners second-generation to represent from produced solution very the goal increasing an that attractive excellent development, for a PHA environment. XX% also this bioplastic well may believe is biodegradable level. consumers We We with to continuing plants the XX% compounders, line brand as and of
pellets. establishing turn the production, an companies, protein, seed see chain, end To variety areas, companies. identity bioplastics chain. processing brand plastics, need owners let's partner seed prospects, we into markets and a oil preserved XX, product on establish value farming based we'll Because to Slide value seed these companies, packaging, contract access biofuel bioplastic and contracting Now of of and to the
over $X XX, end petroleum given to a $X the and yields. in less products market about crop the million with being opportunity is over of billion plastic bioplastic, opportunity on to We products. for Camelina of X $XXX production. persist by X% all could of unique, growing often, Now used grown million oil million being a this consumer let's market plastic there for in bioplastic, million market expect acreage acres replace at revenue history, on protein X.X in around based by Sadly, PHA Based months. for single-use up be to and believe for we use $XXX feedstock the crop on $X $X of functionally an potential for slide share. billion, where XXXX. is lifetime billion of growing single XXXX XX% revenue per scale too our and XX% in X plastics growing PHA of these annual used oil billion that meal. omega-X to items oil of growth depending hundreds to plastics of million And sales believe X know environment, potential a XXX,XXX $XXX after $XXX acres year. with market Over with opportunity, use date, years. oil the is bioplastics We for a estimated quite and to bio-Camelina assuming with million than six they order can a of is XXX,XXX will billion potential we The for -- the XXXX, bioplastic single-use half of could market to of acres, meal, to Camelina be for turn Feedstock growing million
Camelina technology, is costs in to with feedstock PHA disruptive offering a line goal oils. develop Our as
steps are still but some development, take first will commercial it We time. now the clinical towards taking
Now Currently, initial are completing XX, let's the in in our and year, traits CXXXX to with with trait, based test GDM, on licensing have assess of nonexclusive seed X% field we license to our greenhouse. increase achieving we slide our in different turn oil Forage edited canola Simplot in This opportunities. crops. agreements place a some Bayer, research Genetics
and to on plan in corn for traits canola we focus forward, resources seek internal Going Camelina our partners development. to
slide second in with We investments. let XX, XXXX financial quarter turn million cash Now us equivalents results. and to cash, $XX.X ended
of we common with business aligning well better as exercise from public our our raised a During million as sheet warrants, $X.X stock, million from first a the proceeds XXXX, offering $XX of quarter of balance net strategy.
no have debt. We
million was net operating of Our second XXXX. cash usage $X.X for the quarter
expected early hand, current operations to our cash our expect into revenue XXXX. on with We support grant together from government our
activities, range our for $XX will continue the to business XXXX that million and be and our seed scale-up and of million. our seed estimates this year planned well of regulatory cash to the This as operating business hires includes as planned direct usage $XX executing and we estimate We affairs net full as contracted development, within towards other support operations, plan. investment for
second XXXX net second taxes second taxes were versus second Total the of quarter second XXXX, $X.X results. $XXX,XXX second quarter for of $X.X XXXX, the grant as after were quarter of $X.X reported in of to XXXX quarter The million In million now XXXX operating Let's review the expenses the second a of second were expenses G&A loss quarter the $XXX,XXX compared in of after of R&D company the XXXX. loss $X.X XXXX. revenues research in compared second million quarter to a million million net quarter quarter $X.X the million of to for XXXX. XXXX. $X.X compared in in quarter
to million June XX, For in $X.X compared per loss months ending the or XXXX, six million taxes XXXX. $X.XX share, as share per was net our $X.X after or $X.XX
earnings the please to on refer release. details results, financial more For our
to support; XXXX, plan for our field including well the following seed our will germplasm scale-up service business and lines broadening In recent to recently hires America, have to operations XXXX expanding profiles; turn plan capabilities, regulatory particularly business and where continue progressing the engaged development slide as and oil products, internal development. our commercial omega-X to business performance launch Camelina oils milestones: provider Camelina with now Let's our work in seed with Camelina for in we in executing the a desired affairs program; South commercial acquire we as complement seed advancing XX, focus on testing collection milestones. rights elite upcoming our
platform which value be for collaborations the over intellectual call is to secure integral in turn the business, three revenue small gene novel questions. like for feedback, from Camelina major industry as I'd editing see XXXX identification on property increased our genes products patent to we the the genome a commercial on demand for there opportunities Based and partners. like grants back to increasing focus more portfolio, in believe GRAIN generating expanding tools Securing we well on an our and industry to strategic will licenses With effort. chain we As crops. that target this trait trait Lynne trait crucial as company are for unique based